On March 1st, 2021, the long-expected HaifuRNon-invasive Treatment Center was officially opened up in Xiangtan Central Hospital. Wang Zhibiao, Dean of the School of Biomedical Engineering, Chongqing Medical University, Director of the State Key Laboratory of Ultrasound Medical Engineering, and Member of the National Committee of the Chinese People’s Political Consultative Conference, came to the hospital and attended the opening ceremony with hospital leadership team. Xia Hong, Secretary of Hospital Party Committee hosts the ceremony.
Zeng Jianping, the president of the hospital introduced at the opening ceremony thatHigh Intensity Focused Ultrasound (HIFU) researched and developed by professor Wang Zhibiao’s team focuses on ultrasound to realize micro non-invasive treatment in tumor cases. It is also also the first large-scale medical device with completely independent intellectual property rights of our country, making the medical dream of "external treatment of internal diseases" come true. The introduction of HIFU will greatly promote the discipline construction of Xiangtan Central Hospital and set a good start for the new journey of the hospital's "14th Five-Year Plan" construction. Relevant departments such as gynecology and general surgery will make full use of the platform of HaifuRMicro Non-invasive Treatment Center andunder the guidance of professor Wang Zhibiao’s team to seek the well-being of patients' health.
Professor Wang said that performing surgery from outside the body, without trauma or bleeding, fully embodies wide application of big data and intelligence technology. The patient can undergo the operation easily and comfortably in a awake state. After the operation, he can leave the operating room on his own and can go to work the next day, making the operation no longer frightening.
It is understood that the HIFU focalizes ultrasound on the lesion in vivo to form a high-temperature focus, which can be 65-100℃instantly. The high temperature at the focus will kill the tumor cells while the necrotic tissue can be graduallyabsorbed or turned into scars in the body. It will not damage the tissues or organs near the treatment area, effectively retaining the integrity of normal tissues. This subversive technological breakthrough progresses the operation from "invasive" to "micro invasive" andeventually to "non-invasive". According to the feedback of lesion metrology, real-timeultrasound-contrast dynamic images during the treatment process can be used to evaluate the treatment effect in time. At present, this technology could be widely used in the treatment of liver cancer, pancreatic cancer, and bone tumors, breast cancer, uterine fibroids and even cervicitis, allergic rhinitis and other diseases.
Up to now, a series of ultrasonic treatment equipment with core technology mastered by China has been exported to 28 countries and regions. It has treated more than 170,000 patients with benign and malignant tumors and more than 2 million patients with non-tumor diseases worldwide.
